$8.1 billion potential opportunity

Neuropathic Pain Market

Dublin, June 28, 2024 (GLOBE NEWSWIRE) — The “Neuropathic Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034” report has been added. ResearchAndMarkets.com Recruitment.

The 7MM neuropathic pain market reached a value of USD 5.5B in 2023. Going forward, the 7MM is projected to reach USD 8.1B by 2034, exhibiting a CAGR of 4.40% from 2023 to 2034.

This report provides a thorough analysis of the neuropathic pain market in the US, EU5 (Germany, Spain, Italy, France, UK) and Japan, including treatment modalities, marketed and pipeline drugs, share of individual therapies, market performance in seven major markets, and the market performance of key companies and their drugs.

The report also covers the current and future patient population in seven major markets. According to the report, the United States has the largest neuropathic pain patient population and the largest treatment market. Further, the report also covers current treatment methods/algorithms, market drivers, challenges, opportunities, reimbursement scenarios, and unmet medical needs.

Key highlights

• Rise in chronic diseases causing nerve damage and rising incidence of peripheral nerve injuries are primarily driving the global neuropathic pain market.

• In addition to this, the rapid increase in the use of anticonvulsants and tricyclic antidepressants, which stabilize nerve cells and reduce the release of certain neurotransmitters, is further fueling the market growth.

• Additionally, the growing popularity of nerve blocks such as epidural injections to block the transmission of pain signals to the brain is also brightening the market outlook.

• Apart from this, the growing popularity of transcutaneous electrical nerve stimulation (TENS), a non-invasive pain management therapy that uses low-voltage electrical current to stimulate nerve fibers and relieve pain, is also fueling the market growth.

• Moreover, the increasing availability of psychological therapies, such as cognitive behavioral therapy and mindfulness-based interventions, to manage the emotional and psychological aspects of neuropathic pain serves as another important growth driver.

• Moreover, increasing adoption of neurostimulation techniques such as spinal cord stimulation, peripheral nerve stimulation, and deep brain stimulation, which relieve symptoms by stimulating specific pain-related nerves and brain regions, is expected to drive the global neuropathic pain market over the next few years.

The story continues

Research period

Eligible countries

• America

• Germany

• France

• England

• Italy

• Spain

• Japan

Country Analysis

• Past, present and future epidemiological scenarios

• Past, present and future performance of the Neuropathic Pain market

• The past, current and future performance of various therapeutic categories in the market

• Sales of various pharmaceutical products in the neuropathic pain market

Competitive Environment

The report also provides a detailed analysis of currently marketed neuropathic pain treatments as well as pipeline drugs in late-stage development.

Major features

For more information on this report, please visit: https://www.researchandmarkets.com/r/ky8w99

About ResearchAndMarkets.com
ResearchAndMarkets.com is a leading global source of international market research reports and market data providing the latest information on international markets, regional markets, key industries, top companies, new products and latest trends.

Attachments

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900